Dmitry Konyaev, General Director of URALCHEM OJSC, commented
The purchase of the terminal is consistent with our strategic goal of providing logistic security to the supply of our products. For more than 15 years the enterprises of URALCHEM have been customers of the Ventamonjaks. URALCHEM is the leader in Russia in terms of manufacturing ammonia and intends to increase its production. We are keen to provide our customers around the world with flexible and the most favourable conditions for its supply. Our approach to the purchase of the terminal and to its future management will be identical to our existing project - the Riga Fertilizer Terminal.
Andrejs Visnauskas, Chairman of the board of directors of SIA Ventamonjaks, said
The acquisition of shares in the terminal by the manufacturer and owner of the transhipped product provides a long-term guarantee for its workload. This is an important factor for the competitiveness of the terminal, its ability to ensure income for its owners and to provide jobs and taxes for the Latvian budget. We also hope that, with the help of URALCHEM, we will be able to increase the workload of the terminal, which has significantly reduced after the global financial crisis.
Public Relations Department
Tel: +7 (495) 721 89 89
URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.8 million tonnes of ammonia, 2.5 million tonnes of ammonium nitrate, 1.2 million tonnes of urea and 0.8 million tonnes of phosphate and compound fertilizers per year. URALCHEM, OJSC ranks first in Russia for production of ammonia and ammonium nitrate, and second for the production of urea. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.
Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.
+7 (495) 721 89 89
+7 (495) 721 89 89